3
2000L XcellerexTM bioreactors
24x7
campaign operations
3
new purification rooms
3
2000L XcellerexTM bioreactors
24x7
campaign operations
3
new purification rooms
KBI is now offering commercial mammalian manufacturing through its North Carolina single-use facility expansion project.
Building on KBI’s legacy of being the first CMO in the world to implement the 2000L scale Xcellerex™ single-use bioreactor, the first stage of this commercial expansion effort is a commercial manufacturing suite equipped with an initial set of 3X 2000L Xcellerex™ bioreactors and a dedicated purification suite (3 purification rooms).
This commercial manufacturing suite and related equipment are flexible and take advantage of single-use technologies for each unit operation leveraging our extensive experience with large scale single-use equipment.
Learn more about KBI’s deployment of single-use technologies
Publication | Vertical Integration of Disposables in Biopharmaceutical Drug Substance Manufacturing
It will also be operated with strict adherence to regulations required for cGMP biopharmaceutical drug substance manufacturing.
Learn more about our cGMP biologics manufacturing services
The following additional capabilities were added as part of this expansion effort in support of this new commercial manufacturing suite:
Are you looking to accelerate your program or just want to learn more about our services?
Connect with our team and we will get back to you quickly.
View CapabilitiesConnect with our team and we will get back to you quickly.
View CapabilitiesCopyright © 2019 KBI Biopharma. All Rights Reserved. | Privacy Policy